FDA approves J&J's Simponi to treat ulcerative colitis

(Reuters) - The Food and Drug Administration has approved Johnson & Johnson's drug Simponi for patients with moderate to severe ulcerative colitis, an inflammatory disease affecting the colon.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news